DuoO's HRD Test Negative Trial

DuoO had a three arm trial. It was the only trial of the four other trials which required all patients to have bev. And what we found was that there was advantage of the HRD population and then it went to the intent to treat. The challenge here is again, when we look at the brachowile type, because it's all brachOWile type, HRD positive. We need to start talking about curative intent with advanced metastatic ovarian cancer.